CN
| ID | Title |
| e24182 | Comparative genomic profiling of distant metastatic and nondistant metastatic lung adenocarcinoma |
| e24294 | PD-L1 expression and TMB status in newly diagnosed metastatic non-small cell lung cancer and their effect on prognosis after EGFR-TKI or platinum-based chemotherapy |
| e24298 | PD-L1 expression of 742 newly diagnosed advanced respiratory and digestive system tumours in China based on SP142 assay |
| e17543 | Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers |
| e21215 | EGFR and ERBB2 could potentially determine the metastatic status of mediastinal lymph nodes in lung adenocarcinomas harbouring EGFR mutation |
| e16082 | The mutational landscape of circulating cell free DNA in patients with esophageal squamous cell carcinoma response and non-response to neoadjuvant chemotherapy |
| e15662 | The mutational landscape of circulating cell free DNA in patients with colorectal adenoma and carcinoma |
| e16146 | Detection of early recurrence detected in HCC patients after TACE treatment with plasma cfDNA |
| e16063 | Comprehensive genomic profiling of gastric cancer to reveal distinctive genomic alterations between peritoneal metastasis (PM) patients (pts) and non-PM pts |
| e20565 | Differences in small cell lung cancer genetic profile between disease progression (PD) and partial remission (PR) patients after the standard first-line chemotherapy |
East Building #20, 20 Xiushui Road, CMC, Taizhou, P.R. China